SYK management reaffirms full-year growth guidance despite segment softness
Management reaffirmed full-year growth guidance, citing demand strength in capital and trauma/extremities businesses offsetting supply-driven softness in peripheral vascular and joint replacement segments.
Management reaffirmed full-year growth guidance despite ongoing supply challenges in the peripheral vascular and joint replacement segments, while robust demand in the capital and trauma/extremities businesses helped offset the softness. Margin expansion and M&A remain priorities, and management said confidence remains high for the period ahead.